Financials

News Discussions Technicals Seasonals

DTR fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

DiagnosTear Technologies, Inc. operates as an ophthalmic company, which engages in the developing and commercializing disruptive diagnostic solutions for better management of eye diseases. The company was founded on May 10, 2023 and is headquartered in Vancouver, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

DTR does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company